                         SEQUENCE LISTING

<110>  HOX THERAPEUTICS LIMITED
 
<120>  Peptides

<130>  P215.001GB

<160>  95    

<170>  PatentIn version 3.3

<210>  1
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (I). Sequence is linked to Y1 at the
       N-terminus and to Y2 at the C-terminus. Y1 and Y2 are each either
       absent or a peptide comprising a cationic polymer of basic amino 
       acids, provided that at least one of Y1 and Y2 is present.

<220>
<221>  VARIANT
<222>  (1)..(3)
<223>  X1 in Formula (I). Any Xaa may be present or absent - indicates a
       range of 0 - 3 amino acids. If present, X1 is selected from W, T,
       PE, KQI, VV, PQT, H, and RI.

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X2 in Formula (I).  Xaa is an amino acid with an aromatic side 
       chain or cysteine

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X3 in Formula (I).  Xaa is a hydrophobic amino acid

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X4 in Formula (I). Xaa is an amino acid with a charged side 
       chain.

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X5 in Formula (I). Xaa is an amino acid with a basic side chain.

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X6 in Formula (I). Xaa is an amino acid or absent.

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X7 in Formula (I). Xaa is one amino acid or absent. If present, 
       linked to Y2 (if present), either direct or via one or more amino
       acids. (Y2 is a peptide comprising a cationic polymer of basic 
       amino acids).

<400>  1

Xaa Xaa Xaa Xaa Lys Trp Xaa Xaa Xaa Xaa Xaa 
1               5                   10      


<210>  2
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (II). Sequence is linked to Y3 at 
       the N-terminus and to Y4 at the C-terminus. Y3 & Y4 are each 
       either absent or a peptide comprising a cell penetrating moiety, 
       provided that at least one of Y3 and Y4 is present.

<220>
<221>  VARIANT
<222>  (1)..(11)
<223>  At least the N-terminal and C-terminal amino acids of the 
       synthetic peptide of Formula (II), that is SEQ ID NO: 2 with at 
       least one of Y3 and Y4 present, are in the D-conformation.

<220>
<221>  VARIANT
<222>  (1)..(3)
<223>  X1 in Formula (II). Any Xaa may be present or absent - indicates a
       range of 0 - 3 amino acids. If present, X1 is selected from W, T,
       PE, KQI, VV, PQT, H, and RI.

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  X2 in Formula (II).  Xaa is an amino acid with an aromatic side 
       chain or cysteine

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X3 in Formula (II).  Xaa is a hydrophobic amino acid

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X4 in Formula (II). Xaa is an amino acid with a charged side 
       chain.

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X5 in Formula (II). Xaa is an amino acid with a basic side chain.

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X6 in Formula (II). Xaa is an amino acid or absent.

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X7 in Formula (II). Xaa is one amino acid or absent. If present, 
       linked to Y4 (if present), either direct or via one or more amino
       acids. (Y4 is a peptide comprising a cell penetrating moiety).

<400>  2

Xaa Xaa Xaa Xaa Lys Trp Xaa Xaa Xaa Xaa Xaa 
1               5                   10      


<210>  3
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (I). Sequence is linked to Y1 at the
       N-terminus and to Y2 at the C-terminus. Y1 and Y2 are each either
       absent or a peptide comprising a cationic polymer of basic amino 
       acids, provided that at least one of Y1 and Y2 is present.

<400>  3

Trp Tyr Lys Trp Met Lys Lys His His 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (I). Sequence is linked to Y1 at the
       N-terminus and to Y2 at the C-terminus. Y1 and Y2 are each either
       absent or a peptide comprising a cationic polymer of basic amino 
       acids, provided that at least one of Y1 and Y2 is present.

<400>  4

Trp Tyr Lys Trp Met Lys Lys Ala Ala 
1               5                   


<210>  5
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (I). Sequence is linked to Y1 at the
       N-terminus and to Y2 at the C-terminus. Y1 and Y2 are each either
       absent or a peptide comprising a cationic polymer of basic amino 
       acids, provided that at least one of Y1 and Y2 is present.

<400>  5

Trp Tyr Lys Trp Met Lys Lys 
1               5           

<210>  6
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  6

Trp Tyr Lys Trp Met Lys Lys His His Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg 
        


<210>  7
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  7

Trp Tyr Lys Trp Met Lys Lys Ala Ala Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg 
        


<210>  8
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  8

Trp Tyr Lys Trp Met Lys Lys Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


<210>  9
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  9

Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  10

Trp Tyr Lys Trp Met Lys Lys His His 
1               5                   


<210>  11
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  11

Trp Tyr Lys Trp Met Lys Lys His His Arg 
1               5                   10  


<210>  12
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  12

Trp Tyr Lys Trp Met Lys Lys Ala Ala 
1               5                   


<210>  13
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  13

Trp Tyr Lys Trp Met Lys Lys Ala Ala Arg 
1               5                   10  


<210>  14
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  14

Trp Tyr Lys Trp Met Lys Lys 
1               5           


<210>  15
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  15

Trp Tyr Lys Trp Met Lys Lys Arg 
1               5               


<210>  16
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (II). Sequence is linked to Y3 at 
       the N-terminus and to Y4 at the C-terminus. Y3 & Y4 are each 
       either absent or a peptide comprising a cell penetrating moiety, 
       provided that at least one of Y3 and Y4 is present.


<220>
<221>  VARIANT
<222>  (1)..(9)
<223>  At least the N-terminal and C-terminal amino acids of the 
       synthetic peptide of Formula (II), that is SEQ ID NO: 16 with at 
       least one of Y3 and Y4 present, are in the D-conformation.

<400>  16

Trp Tyr Lys Trp Met Lys Lys His His 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (II). Sequence is linked to Y3 at 
       the N-terminus and to Y4 at the C-terminus. Y3 & Y4 are each 
       either absent or a peptide comprising a cell penetrating moiety, 
       provided that at least one of Y3 and Y4 is present.


<220>
<221>  VARIANT
<222>  (1)..(9)
<223>  At least the N-terminal and C-terminal amino acids of the 
       synthetic peptide of Formula (II), that is SEQ ID NO: 17 with at 
       least one of Y3 and Y4 present, are in the D-conformation.

<400>  17

Trp Tyr Lys Trp Met Lys Lys Ala Ala 
1               5                   


<210>  18
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide of Formula (II). Sequence is linked to Y3 at 
       the N-terminus and to Y4 at the C-terminus. Y3 & Y4 are each 
       either absent or a peptide comprising a cell penetrating moiety, 
       provided that at least one of Y3 and Y4 is present.


<220>
<221>  VARIANT
<222>  (1)..(7)
<223>  At least the N-terminal and C-terminal amino acids of the 
       synthetic peptide of Formula (II), that is SEQ ID NO: 18 with at 
       least one of Y3 and Y4 present, are in the D-conformation.

<400>  18

Trp Tyr Lys Trp Met Lys Lys 
1               5           


<210>  19
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  19

Trp Cys Lys Trp Leu Asp Arg His Gly 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  20

Trp Tyr Lys Trp Val Lys Lys His His 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  21

Trp Tyr Lys Trp Ile Lys Lys His His 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  22

Trp Tyr Lys Trp Met Arg Lys His His 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  23

Trp Tyr Lys Trp Met Lys Arg His His 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  24

Trp Tyr Lys Trp Met Arg Arg His His 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  25

Trp Tyr Lys Trp Met Lys Lys Thr His 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  26

Trp Tyr Lys Trp Met Lys Lys His Thr 
1               5                   


<210>  27
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  27

Trp Tyr Lys Trp Met Lys Lys Thr Thr 
1               5                   


<210>  28
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  28

Trp Cys Lys Trp Met Lys Lys His His 
1               5                   


<210>  29
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  29

Trp Cys Lys Trp Met Arg Lys His His 
1               5                   


<210>  30
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa may be present or absent. If present, Xaa is Arg or Gln

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  Xaa is Ile or Leu

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is Lys or Arg

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  Xaa is Ile or Leu

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  Xaa is Lys or Arg

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  Xaa is Lys or Arg

<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  Xaa is Lys or Arg

<220>
<221>  VARIANT
<222>  (15)..(16)
<223>  Xaa is Lys or Arg

<400>  30

Xaa Gln Xaa Xaa Xaa Trp Phe Gln Asn Xaa Xaa Met Xaa Trp Xaa Xaa 
1               5                   10                  15      


<210>  31
<211>  25
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  31

Trp Tyr Lys Trp Met Lys Lys His His Arg Gln Ile Lys Ile Trp Phe 
1               5                   10                  15      


Gln Asn Arg Arg Met Lys Trp Lys Lys 
            20                  25  


<210>  32
<211>  25
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  32

Trp Tyr Lys Trp Met Lys Lys Ala Ala Arg Gln Ile Lys Ile Trp Phe 
1               5                   10                  15      


Gln Asn Arg Arg Met Lys Trp Lys Lys 
            20                  25  


<210>  33
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  33

Trp Tyr Lys Trp Met Lys Lys Arg Gln Ile Lys Ile Trp Phe Gln Asn 
1               5                   10                  15      


Arg Arg Met Lys Trp Lys Lys 
            20              


<210>  34
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  34

Trp Tyr Lys Trp Met Lys Lys His His Arg Gln Ile Lys Ile Trp Phe 
1               5                   10                  15      


Gln Asn Arg Arg Met Lys Trp Lys 
            20                  


<210>  35
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  35

Trp Tyr Lys Trp Met Lys Lys Ala Ala Arg Gln Ile Lys Ile Trp Phe 
1               5                   10                  15      


Gln Asn Arg Arg Met Lys Trp Lys 
            20                  


<210>  36
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  36

Trp Tyr Lys Trp Met Lys Lys Arg Gln Ile Lys Ile Trp Phe Gln Asn 
1               5                   10                  15      


Arg Arg Met Lys Trp Lys 
            20          


<210>  37
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  37

Trp Cys Lys Trp Met Lys Arg His His 
1               5                   


<210>  38
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  38

Trp Cys Lys Trp Met Arg Arg His His 
1               5                   


<210>  39
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  39

Trp Tyr Lys Trp Met Lys Arg Thr His 
1               5                   


<210>  40
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  40

Trp Tyr Lys Trp Met Arg Lys Thr His 
1               5                   


<210>  41
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  41

Trp Tyr Lys Trp Met Arg Arg Thr His 
1               5                   


<210>  42
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  42

Trp Tyr Lys Trp Met Arg Lys His Thr 
1               5                   


<210>  43
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  43

Trp Tyr Lys Trp Met Lys Arg His Thr 
1               5                   


<210>  44
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  44

Trp Tyr Lys Trp Met Arg Arg His Thr 
1               5                   


<210>  45
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  45

Trp Tyr Lys Trp Met Arg Arg Thr Thr 
1               5                   


<210>  46
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  46

Trp Tyr Lys Trp Leu Arg Lys His His 
1               5                   


<210>  47
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  47

Trp Tyr Lys Trp Leu Lys Arg His His 
1               5                   


<210>  48
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  48

Trp Tyr Lys Trp Met Lys Lys His 
1               5               


<210>  49
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  49

Trp Cys Lys Trp Leu Asp Arg Ala Gly 
1               5                   


<210>  50
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  50

Trp Tyr Lys Trp Val Lys Lys Ala Ala 
1               5                   


<210>  51
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  51

Trp Tyr Lys Trp Ile Lys Lys Ala Ala 
1               5                   


<210>  52
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  52

Trp Tyr Lys Trp Met Arg Lys Ala Ala 
1               5                   


<210>  53
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  53

Trp Tyr Lys Trp Met Lys Arg Ala Ala 
1               5                   


<210>  54
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  54

Trp Tyr Lys Trp Met Arg Arg Ala Ala 
1               5                   


<210>  55
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  55

Trp Tyr Lys Trp Met Lys Lys Thr Ala 
1               5                   


<210>  56
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  56

Trp Tyr Lys Trp Met Lys Lys Ala Thr 
1               5                   


<210>  57
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  57

Trp Cys Lys Trp Met Lys Lys Ala Ala 
1               5                   


<210>  58
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  58

Trp Cys Lys Trp Met Arg Lys Ala Ala 
1               5                   


<210>  59
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  59

Trp Cys Lys Trp Met Lys Arg Ala Ala 
1               5                   


<210>  60
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  60

Trp Cys Lys Trp Met Arg Arg Ala Ala 
1               5                   


<210>  61
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  61

Trp Tyr Lys Trp Met Lys Arg Thr Ala 
1               5                   


<210>  62
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  62

Trp Tyr Lys Trp Met Arg Lys Thr Ala 
1               5                   


<210>  63
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  63

Trp Tyr Lys Trp Met Arg Arg Thr Ala 
1               5                   


<210>  64
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  64

Trp Tyr Lys Trp Met Arg Lys Ala Thr 
1               5                   


<210>  65
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  65

Trp Tyr Lys Trp Met Lys Arg Ala Thr 
1               5                   


<210>  66
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  66

Trp Tyr Lys Trp Met Arg Arg Ala Thr 
1               5                   


<210>  67
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  67

Trp Tyr Lys Trp Leu Arg Lys Ala Ala 
1               5                   


<210>  68
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  68

Trp Tyr Lys Trp Leu Lys Arg Ala Ala 
1               5                   


<210>  69
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  69

Trp Tyr Lys Trp Met Lys Lys Ala 
1               5               


<210>  70
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  70

Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  71
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  71

Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  72
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  72

Gln Ile Lys Ile Trp Phe Gln Asn Lys Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  73
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  73

Gln Ile Lys Ile Trp Phe Gln Asn Lys Lys Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  74
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  74

Gln Ile Arg Ile Trp Phe Gln Asn Arg Lys Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  75
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  75

Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Arg Trp Lys Lys 
1               5                   10                  15  


<210>  76
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  76

Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Arg Lys 
1               5                   10                  15  


<210>  77
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  77

Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Arg 
1               5                   10                  15  


<210>  78
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  78

Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Arg Arg 
1               5                   10                  15  


<210>  79
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  79

Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  80
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  80

Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Arg Lys 
1               5                   10                  15  


<210>  81
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  81

Gln Ile Arg Ile Trp Phe Gln Asn Lys Arg Met Lys Trp Arg Lys 
1               5                   10                  15  


<210>  82
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  82

Gln Ile Lys Leu Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  83
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  83

Gln Leu Lys Leu Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  84
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  84

Gln Leu Arg Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210>  85
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide (HOX hexapeptide sequence)

<400>  85

Trp Tyr Pro Trp Met Lys Lys 
1               5           


<210>  86
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Control synthetic peptide HXR9

<400>  86

Trp Tyr Pro Trp Met Lys Lys His His Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg 
        


<210>  87
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Control synthetic peptide CXR9

<400>  87

Trp Tyr Pro Ala Met Lys Lys His His Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg 
        


<210>  88
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Control synthetic peptide HXR9AS7

<400>  88

Trp Tyr Pro Trp Met Lys Lys Ala Ala Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg 
        


<210>  89
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Control synthetic peptide HXR9noH

<400>  89

Trp Tyr Pro Trp Met Lys Lys Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


<210>  90
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  90

Arg Arg Arg Arg Arg Arg 
1               5       


<210>  91
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  91

Arg Arg Arg Arg Arg Arg Arg 
1               5           


<210>  92
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  92

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  93
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  93

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10  


<210>  94
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  94

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10      


<210>  95
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  95

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10          


